Literature DB >> 12594210

Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization.

Ricardo M Richardson1, Kenzo Tokunaga, Robin Marjoram, Tetsutaro Sata, Ralph Snyderman.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) entry into CD4(+) cells requires the chemokine receptors CCR5 or CXCR4 as co-fusion receptors. We have previously demonstrated that chemokine receptors are capable of cross-regulating the functions of each other and, thus, affecting cellular responsiveness at the site of infection. To investigate the effects of chemokine receptor cross-regulation in HIV-1 infection, monocytes and MAGIC5 and rat basophilic leukemia (RBL-2H3) cell lines co-expressing the interleukin-8 (IL-8 or CXCL8) receptor CXCR1 and either CCR5 (ACCR5) or CXCR4 (ACXCR4) were generated. IL-8 activation of CXCR1, but not the IL-8 receptor CXCR2, cross-phosphorylated CCR5 and CXCR4 and cross-desensitized their responsiveness to RANTES (regulated on activation normal T cell expressed and secreted) (CCL5) and stromal derived factor (SDF-1 or CXCL12), respectively. CXCR1 activation internalized CCR5 but not CXCR4 despite cross-phosphorylation of both. IL-8 pretreatment also inhibited CCR5- but not CXCR4-mediated virus entry into MAGIC5 cells. A tail-deleted mutant of CXCR1, DeltaCXCR1, produced greater signals upon activation (Ca(2+) mobilization and phosphoinositide hydrolysis) and cross-internalized CXCR4, inhibiting HIV-1 entry. The protein kinase C inhibitor staurosporine prevented phosphorylation and internalization of the receptors by CXCR1 activation. Taken together, these results indicate that chemokine receptor-mediated HIV-1 cell infection is blocked by receptor internalization but not desensitization alone. Thus, activation of chemokine receptors unrelated to CCR5 and CXCR4 may play a cross-regulatory role in the infection and propagation of HIV-1. Since DeltaCXCR1, but not CXCR1, cross-internalized and cross-inhibited HIV-1 infection to CXCR4, the data indicate the importance of the signal strength of a receptor and, as a consequence, protein kinase C activation in the suppression of HIV-1 infection by cross-receptor-mediated internalization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594210     DOI: 10.1074/jbc.M211745200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Regulation of neutrophil trafficking from the bone marrow.

Authors:  Ryan B Day; Daniel C Link
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

Review 2.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.

Authors:  Kevin O Saunders; Cavin Ward-Caviness; Robert J Schutte; Stephanie A Freel; R Glenn Overman; Nathan M Thielman; Coleen K Cunningham; Thomas B Kepler; Georgia D Tomaras
Journal:  Cell Immunol       Date:  2010-10-27       Impact factor: 4.868

Review 4.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

5.  Heterologous regulation of CXCR4 lysosomal trafficking.

Authors:  Adriana Caballero; Sarah A Mahn; Mudassir S Ali; M Rose Rogers; Adriano Marchese
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

6.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

Authors:  Kyle J Eash; Jacquelyn M Means; Douglas W White; Daniel C Link
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

7.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

8.  Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Authors:  Matthew J Finley; Xiaohong Chen; Guiseppe Bardi; Penny Davey; Ellen B Geller; Lily Zhang; Martin W Adler; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2008-06-03       Impact factor: 3.478

9.  CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1).

Authors:  Teresa G D'Aversa; Eliseo A Eugenin; Joan W Berman
Journal:  J Neurosci Res       Date:  2008-02-15       Impact factor: 4.164

10.  A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients.

Authors:  A Vasilescu; Y Terashima; M Enomoto; S Heath; V Poonpiriya; H Gatanaga; H Do; G Diop; T Hirtzig; P Auewarakul; D Lauhakirti; T Sura; P Charneau; S Marullo; A Therwath; S Oka; S Kanegasaki; M Lathrop; K Matsushima; J-F Zagury; F Matsuda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.